Hemophagocytic Lymphohistiocytosis: An Underrecognized Complication of Pediatric Crimean-Congo Hemorrhagic Fever.

Authors

Kubra Aykac, Ozlem Cakici, Aylin Irmak Kuruc, Canan Ozlu, Pınar Koc, Bera Enes Seyrek, Tekin Aksu, Selin Aytac, Hanife Avci, Ali Bulent Cengiz, Yasemin Ozsurekci

Published in

Pediatrics international : official journal of the Japan Pediatric Society. Volume 68. Issue 1. Pages e70575.

Abstract

Secondary hemophagocytic lymphohistiocytosis (sHLH) is a potentially life-threatening hyperinflammatory complication of Crimean-Congo hemorrhagic fever (CCHF), yet pediatric data remain limited. This study aimed to characterize the clinical phenotype of pediatric CCHF-associated sHLH and to identify early clinical features associated with sHLH development.
PCR-confirmed pediatric CCHF cases from four tertiary centers in Türkiye (2018-2025) were retrospectively analyzed, and clinical characteristics, laboratory findings, treatment, and outcomes were compared between children with and without sHLH.
Of 79 patients, 27 (34.2%) fulfilled the diagnostic criteria for sHLH. Compared with children without sHLH, these patients more frequently presented with hemorrhagic findings (44.4% vs. 11.5%, p = 0.002), diarrhea (37.0% vs. 7.7%, p = 0.004), and bradycardia (25.9% vs. 1.9%, p = 0.002), and had lower platelet and fibrinogen and higher ferritin, AST, ALT, and LDH concentrations at diagnosis. On multivariable analysis, bradycardia (OR 11.1, 95% CI 1.7-126.3), hemorrhagic findings (OR 7.1, 95% CI 2.1-26.5), and diarrhea (OR 6.4, 95% CI 1.6-29.0) remained independent predictors; hemorrhagic findings and diarrhea preceded the sHLH diagnosis, whereas bradycardia was identified concurrently. Ferritin and aPTT worsened progressively only in children with sHLH, whereas platelet count declined in both groups. Despite more frequent immunomodulatory therapy and transfusion, no deaths occurred.
Secondary HLH should be actively considered in pediatric CCHF, particularly with hemorrhagic findings, diarrhea, or bradycardia preceding full laboratory evolution to facilitate earlier diagnosis and timely therapy.

PMID:
42898033
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.